Concomitant i.v. and oral clodronate in the relief of bone pain - a double-blind placebo-controlled study in patients with prostate cancer

Fifty-seven patients with advanced prostate cancer resistant to first-line hormonal therapy were treated with estramustine and additionally randomized for treatment with clodronate or placebo. Clodronate treatment was started with 5 days intravenous administration (300 mg day[-1]) and followed by or...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of cancer Vol. 76; no. 7; pp. 939 - 942
Main Authors KYLMÄLÄ, T, TAUBE, T, TAMMELA, T. L. J, RISTELI, L, RISTELI, J, ELOMAA, I
Format Journal Article
LanguageEnglish
Published Basingstoke Nature Publishing Group 01.01.1997
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Fifty-seven patients with advanced prostate cancer resistant to first-line hormonal therapy were treated with estramustine and additionally randomized for treatment with clodronate or placebo. Clodronate treatment was started with 5 days intravenous administration (300 mg day[-1]) and followed by oral treatment (1.6 g day[-1]) for 12 months. Skeletal pain relief was only about 10% better in the clodronate than in the placebo group. The results do not support the superiority of combined intravenous and oral treatment with clodronate compared with oral administration only.
AbstractList Fifty-seven patients with advanced prostate cancer resistant to first-line hormonal therapy were treated with estramustine and additionally randomized for treatment with clodronate or placebo. Clodronate treatment was started with 5 days intravenous administration (300 mg day[-1]) and followed by oral treatment (1.6 g day[-1]) for 12 months. Skeletal pain relief was only about 10% better in the clodronate than in the placebo group. The results do not support the superiority of combined intravenous and oral treatment with clodronate compared with oral administration only.
Fifty-seven patients with advanced prostate cancer resistant to first-line hormonal therapy were treated with estramustine and additionally randomized for treatment with clodronate or placebo. Clodronate treatment was started with 5 days intravenous administration (300 mg day super(-1)) and followed by oral treatment (1.6 g day super(-1)) for 12 months. Skeletal pain relief was only about 10% better in the clodronate than in the placebo group. The results do not support the superiority of combined intravenous and oral treatment with clodronate compared with oral administration only.
Author TAUBE, T
RISTELI, L
RISTELI, J
KYLMÄLÄ, T
ELOMAA, I
TAMMELA, T. L. J
AuthorAffiliation Department of Surgery, Tampere University Hospital, Finland
AuthorAffiliation_xml – name: Department of Surgery, Tampere University Hospital, Finland
Author_xml – sequence: 1
  givenname: T
  surname: KYLMÄLÄ
  fullname: KYLMÄLÄ, T
  organization: Division of Urology, Department of Surgery, Tampere University Hospital, Finland
– sequence: 2
  givenname: T
  surname: TAUBE
  fullname: TAUBE, T
  organization: Department of Oncology, University of Helsinki, Finland
– sequence: 3
  givenname: T. L. J
  surname: TAMMELA
  fullname: TAMMELA, T. L. J
  organization: Division of Urology, Department of Surgery, Tampere University Hospital, Finland
– sequence: 4
  givenname: L
  surname: RISTELI
  fullname: RISTELI, L
  organization: Departments of Medical Biochemistry and Clinical Chemistry, University of Oulu, Finland
– sequence: 5
  givenname: J
  surname: RISTELI
  fullname: RISTELI, J
  organization: Departments of Medical Biochemistry and Clinical Chemistry, University of Oulu, Finland
– sequence: 6
  givenname: I
  surname: ELOMAA
  fullname: ELOMAA, I
  organization: Department of Oncology, University of Helsinki, Finland
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2812331$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/9328156$$D View this record in MEDLINE/PubMed
BookMark eNpVkUuLFDEUhYOMjD2jO7dCFuLKKvOoR7IRpPEFA250HVKpGztDOimT1Mj8BX-1KbppdFWkzpdz7s25QVchBkDoJSUtJVy8m-5NS6Uc206IJ2hHe84aKth4hXaEkLEhkpFn6Cbn-3qURIzX6FpyJmg_7NCffQwmHl3RoWDXPrRYhxnHpD02Ps4pBl0Au4DLAXAC78DiaPFUR8CLrv8brPEc18lDM3lX7y5eG5hiY2IoKXoPM85lnR83k0UXB6Fk_NuVA15SzGWzNzoYSM_RU6t9hhfn7y368enj9_2X5u7b56_7D3eN6YauNHIQMzDNhbb9CIMFUjfh1pgRDBBttJEdcEmBAaHGUjn0IKzsSM97MUvDb9H7k--yTkeYTR2orquW5I46PaqonfpfCe6gfsYHxRgTZBiqwZuzQYq_VshFHV024L0OENes6MD7cehoBd-eQFM3zQnsJYQStXWnandq607V7ir-6t_BLvC5rKq_Pus6G-1tqs_m8gWrEON8S8UnrFa3JrjoNWuL2pL-AvKJses
CODEN BJCAAI
CitedBy_id crossref_primary_10_1016_S0305_7372_03_00071_9
crossref_primary_10_1016_j_clon_2004_07_009
crossref_primary_10_1097_00042307_200209000_00008
crossref_primary_10_1007_s11916_000_0078_3
crossref_primary_10_1016_j_eursup_2004_08_009
crossref_primary_10_1097_00042307_200405000_00008
crossref_primary_10_1111_pme_12016
crossref_primary_10_1002_14651858_CD005247_pub2
crossref_primary_10_1016_j_eursup_2004_08_010
crossref_primary_10_1038_sj_pcan_4500607
crossref_primary_10_1097_00045391_200401000_00012
crossref_primary_10_3816_CGC_2002_n_016
crossref_primary_10_1016_S0022_5347_05_65498_5
crossref_primary_10_1586_ecp_12_21
crossref_primary_10_1634_theoncologist_2008_0209
crossref_primary_10_1179_joc_2005_17_5_555
crossref_primary_10_1097_00001622_199905000_00016
crossref_primary_10_1111_iju_13170
crossref_primary_10_1177_0269216316639793
crossref_primary_10_1517_14712598_6_12_1333
crossref_primary_10_1517_14728214_8_2_469
crossref_primary_10_1200_JCO_2003_05_147
crossref_primary_10_4137_CMT_S1958
crossref_primary_10_1016_j_bone_2020_115715
crossref_primary_10_1097_00000421_200212001_00003
crossref_primary_10_1002_14651858_CD006250_pub2
crossref_primary_10_1016_j_ejca_2012_07_016
crossref_primary_10_3390_ijms17091415
crossref_primary_10_1016_j_eururo_2006_05_017
crossref_primary_10_1016_S0002_9343_02_01101_4
crossref_primary_10_1046_j_1464_410X_2003_04494_x
crossref_primary_10_1007_s10585_009_9247_x
crossref_primary_10_1177_030089160308900301
crossref_primary_10_1002_14651858_CD006250
crossref_primary_10_1007_s00345_004_0472_2
crossref_primary_10_1016_S0305_7372_03_00013_6
crossref_primary_10_1200_JCO_1999_17_7_1969
crossref_primary_10_1191_026921601671919596
crossref_primary_10_1097_00005392_200112000_00004
crossref_primary_10_1634_theoncologist_9_90004_14
crossref_primary_10_3904_kjm_2017_92_2_124
crossref_primary_10_1038_sj_pcan_4500705
crossref_primary_10_1093_jnci_94_19_1458
crossref_primary_10_1517_14656566_9_16_2829
crossref_primary_10_1016_j_ctrv_2019_05_003
crossref_primary_10_1081_CNV_120014886
crossref_primary_10_1002_14651858_CD013020_pub2
crossref_primary_10_1002_14651858_CD002068
crossref_primary_10_1016_j_ucl_2004_01_001
crossref_primary_10_1111_j_1442_2042_2010_02468_x
crossref_primary_10_1191_026921600701536372
crossref_primary_10_1007_s11912_006_0023_7
crossref_primary_10_3816_SCT_2006_n_012
crossref_primary_10_1002_cncr_20056
crossref_primary_10_1016_j_hoc_2006_03_011
crossref_primary_10_1016_j_ctrv_2004_03_005
crossref_primary_10_3816_CGC_2005_n_009
crossref_primary_10_2165_00024669_200302060_00004
crossref_primary_10_1188_09_CJON_701_710
crossref_primary_10_1053_j_seminoncol_2010_10_002
crossref_primary_10_1007_s00120_019_0881_x
ContentType Journal Article
Copyright 1997 INIST-CNRS
Copyright_xml – notice: 1997 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QP
5PM
DOI 10.1038/bjc.1997.488
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Calcium & Calcified Tissue Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Calcium & Calcified Tissue Abstracts
DatabaseTitleList
Calcium & Calcified Tissue Abstracts
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-1827
EndPage 942
ExternalDocumentID 10_1038_bjc_1997_488
9328156
2812331
bjc1997488
Genre Clinical Trial
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
-Q-
02
08R
0R
23N
39C
3V.
4.4
53G
55
5GY
5RE
70F
7RV
7X7
88E
8AO
8C1
8FI
8FJ
8R4
8R5
8WZ
A6W
AADWK
AAPBV
AAWBL
AAWTL
AAYJO
AAZLF
ABAWZ
ABDBF
ABDEU
ABFLS
ABGIJ
ABOCM
ABPTK
ABUWG
ACGFS
ACKTT
ACPRK
ADACO
ADBBV
ADBIT
ADHDB
ADQMX
AEDAW
AEJRE
AENEX
AEXYK
AFKRA
AFRAH
AFSHS
AGEZK
AHMBA
AHSBF
AJRNO
ALFFA
ALMA_UNASSIGNED_HOLDINGS
AN0
ASPBG
AVWKF
AXYYD
AZFZN
B0M
BAWUL
BBAFP
BBNVY
BENPR
BHPHI
BKEYQ
BKKNO
BNQBC
BPHCQ
BVXVI
CAG
COF
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBC
EBD
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMK
EPL
ESX
EX3
F5P
FDQFY
FEDTE
FERAY
FIZPM
FRJ
FSGXE
FYUFA
GJ
GX1
HCIFZ
HVGLF
HYE
HZ
IH2
J5H
JSO
KQ8
M1P
M41
M7P
NAO
NAPCQ
O9-
OK1
P2P
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
Q-
Q2X
RIG
RNT
RNTTT
RPM
SNX
SNYQT
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TR2
TUS
UDS
VH1
W2D
WH7
WOW
X7M
XFK
Y6R
ZA5
ZGI
---
.55
.GJ
0R~
36B
406
6J9
AANZL
AATNV
AAUGY
AAYFA
ABLJU
ACBMV
ACBRV
ACBYP
ACGFO
ACIGE
ACRQY
ACTTH
ACVWB
ADFRT
ADMDM
ADYYL
AEFTE
AEVLU
AFNRJ
AGAYW
AGGBP
AGHAI
AI.
AILAN
AJCLW
AJDOV
AMRJV
AMYLF
AOIJS
CCPQU
DNIVK
DPUIP
EMOBN
HZ~
IQODW
IWAJR
JZLTJ
NQJWS
NYICJ
SOHCF
SRMVM
UKHRP
~02
~8M
AACDK
AASML
ABAKF
ABZZP
ACAOD
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AIGIU
CGR
CUY
CVF
ECM
EIF
FIGPU
HMCUK
NPM
AAYXX
CITATION
7QP
5PM
ID FETCH-LOGICAL-c464t-968de2a38af57e6fe08153fcc7ece0acac94e391e2e01cf1965e8f9405358d9c3
IEDL.DBID RPM
ISSN 0007-0920
IngestDate Tue Sep 17 21:24:33 EDT 2024
Thu Aug 15 23:21:58 EDT 2024
Fri Aug 23 02:27:04 EDT 2024
Sat Sep 28 08:35:43 EDT 2024
Sun Oct 29 17:08:48 EDT 2023
Thu Oct 07 19:38:39 EDT 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Human
Urinary system disease
Intravenous administration
Prostate disease
Diseases of the osteoarticular system
Oral administration
Malignant tumor
Chemotherapy
Randomization
Analgesic
Pain
Treatment
Double blind study
Advanced stage
Bone
Male genital diseases
Prostate
Language English
License CC BY 4.0
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c464t-968de2a38af57e6fe08153fcc7ece0acac94e391e2e01cf1965e8f9405358d9c3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228066/
PMID 9328156
PQID 16357641
PQPubID 23462
PageCount 4
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2228066
proquest_miscellaneous_16357641
crossref_primary_10_1038_bjc_1997_488
pubmed_primary_9328156
pascalfrancis_primary_2812331
nature_primary_bjc1997488
ProviderPackageCode ABDEU
AEDAW
AAZLF
-Q-
AADWK
AAYJO
70F
ADQMX
EE.
RNTTT
SWTZT
ABGIJ
RNT
NAO
PublicationCentury 1900
PublicationDate 1997-01-01
PublicationDateYYYYMMDD 1997-01-01
PublicationDate_xml – month: 01
  year: 1997
  text: 1997-01-01
  day: 01
PublicationDecade 1990
PublicationPlace Basingstoke
PublicationPlace_xml – name: Basingstoke
– name: England
PublicationTitle British journal of cancer
PublicationTitleAlternate Br J Cancer
PublicationYear 1997
Publisher Nature Publishing Group
Publisher_xml – name: Nature Publishing Group
SSID ssj0009087
Score 1.881078
Snippet Fifty-seven patients with advanced prostate cancer resistant to first-line hormonal therapy were treated with estramustine and additionally randomized for...
SourceID pubmedcentral
proquest
crossref
pubmed
pascalfrancis
nature
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 939
SubjectTerms Administration, Oral
Aged
Aged, 80 and over
Analgesics
Analgesics, Non-Narcotic - administration & dosage
Analgesics, Non-Narcotic - adverse effects
Analgesics, Non-Narcotic - therapeutic use
Biological and medical sciences
Bone Neoplasms - metabolism
Bone Neoplasms - secondary
Clodronic Acid - administration & dosage
Clodronic Acid - adverse effects
Clodronic Acid - therapeutic use
Collagen - metabolism
Double-Blind Method
Humans
Injections, Intravenous
Male
Medical sciences
Middle Aged
Neuropharmacology
Pain - drug therapy
Pain - metabolism
Peptide Fragments - blood
Pharmacology. Drug treatments
Procollagen - blood
Prospective Studies
Prostatic Neoplasms - metabolism
Prostatic Neoplasms - pathology
Title Concomitant i.v. and oral clodronate in the relief of bone pain - a double-blind placebo-controlled study in patients with prostate cancer
URI http://dx.doi.org/10.1038/bjc.1997.488
https://www.ncbi.nlm.nih.gov/pubmed/9328156
https://search.proquest.com/docview/16357641
https://pubmed.ncbi.nlm.nih.gov/PMC2228066
Volume 76
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZ50BIoIX2EunlUh_Yor23Jr2OydAmFDT00kJuR5RF12chmH_0P_ded8Yts6annkYTwN2Y-jWY-MfYpqnISQYkEabELFdlYlGFohE2VUaFBv7bUjby8T-4e1NfH-PGAxWMvTFe0b8rad6sn39U_utrK9snMxjqx2bflnLIWGCpnh-wwlXI8oo9Ku0HWC2VSDi6PgqHaPZDZrPxpqDsv9dFrT9gLpC6klbIXkSY9zVet3uBXsv3zFv_in3-XUT6LS4szdjoQSn7Tb_w1OwD3hr1cDlfmb9nveePQq2p6LZjX_i-fa1dx6svnZtVUa8qeA68dRybI14CU1PLG8rJxwFtdOyE0r5pduQJRIiWteFfFVTZiKHJfQcU7jVpaY1Bp3XBK7_KWOkpodUOutX7HHhZfvs_vxPD-gjAqUVuRJ1kFkZaZtnEKiQWkD7G0xqRgINBGm1yBzEOIIAiNJW1CyGyuSDImq3Ijz9mRw92-ZzzXJlHWxDmkCZ5YY026RyaDrJISA6X22OcRg6LtZTaK7npcZgWiVhBqBaLmMa8HaBqFVjJ2tqs9zKYhiHIkZeixjyOGBf5DdDGiHTS7TRGSKF-icMR5j-g0dXARj6V7UE92Eufet6DPdiLdg49--O-ZF-ykl8qldM8lO9qud3CFBGhbXrPjm8Xt7f115_h_AE0OCS0
link.rule.ids 230,315,733,786,790,891,27957,27958,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Lb9QwEMdHpQhaCfFsRYBSH-DobBI7ryNaUS3QrTi0qLfIcWwR2DqrfXDgG_CtmclLbMUFzuNYSfy3PB7P_AzwJqpygqBEnFjsXEY25mUYam5TqWWoUdeWqpHnF8nsSn68jq_3IB5qYdqkfV3Wvlvc-K7-2uZWLm_0ZMgTm3yeTylqgUvl5A7cxfkapcMmfWDtBlmHyqQoXB4Ffb57ILJJ-U1TfV7qo24P4R46L0RL2VmTRqLmg6Va43-y3QUXf_NAbydS_rEynT2CL8M3dQkp3_3tpvT1z1u4x3_-6MfwsPdV2bvO_AT2jHsK9-f9afwz-DVtHAq2pouIWe3_8JlyFaOSf6YXTbWiwLxhtWPoZLKVQW_XssaysnGGLVXtOFesarblwvASvd2KtQliZcP7_PmFqViLv6U-egDsmlHkmC2pWIV616Ta1RFcnb2_nM54f7UD1zKRG54nWWUiJTJl49Qk1qBnEgurdWq0CZRWOpdG5KGJTBBqS9hDk9lcEo0mq3ItjmHf4ds-B5YrnUir49ykCW6GY0VIJZ2ZrBIC12DlwdthcItlR_Ao2pN3kRUoh4LkUKAcPPC6kR9boZWMre1kRwxjE5RPJETowekgjgKnJ525KGea7boIifeXSGxx3EllfLTXngfpjoZGO3G_dy2ojJb_3SvhxX8_eQoHs8v5eXH-4eLTSzjsiLwUVXoF-5vV1pygn7UpX7ez6jdRWSmj
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Jb9UwEMctKKKqhNirBij1AY7OZmc7ogdPZXlVD1SquESOFxF4daK39MA34Fszk019Faeex7bi-G95PB7_TMi7WBcIQYkZstiZiG3CqihSzGZCiUiBri3eRl6cpacX4stlcnnjqa8uaV9Vte-WV76rf3a5le2VCsY8seB8McOoBSyVQattcJ88gDkbF-NGfeTthnmPy8RIXBGHQ857yPOg-qXwjl7mg3YPyENwYJCYsrMuTVTNR61cw7-y_SMX__NCbydT3lid5k_Ij7FffVLKb3-7qXz15xby8U4df0oeDz4r_dAXeUbuGfec7C-GU_kX5O-scSDcGh8kprV_7VPpNMWr_1QtG73CAL2htaPgbNKVAa_X0sbSqnGGtrJ2jEmqm221NKwCr1fTLlGsatiQR780mnYYXGxjAMGuKUaQaYuXVrB1hepdvSQX80_fZ6dseOKBKZGKDSvSXJtY8lzaJDOpNeChJNwqlRllQqmkKoThRWRiE0bKIv7Q5LYQSKXJdaH4Idlz8LVHhBZSpcKqpDBZCpviRCJaSeUm15zDWiw98n4c4LLtSR5ldwLP8xIkUaIkSpCER7x-9KdSYEVjZzveEcRUBCQUcx555GQUSAnTFM9epDPNdl1GyP1LBZQ47OUyVR3055FsR0eTHfnfuxZQR8cBH9Tw6s41T8j--cd5-e3z2dfX5KAH82Jw6Q3Z26y25hjcrU31tptY_wCClywj
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Concomitant+i.v.+and+oral+clodronate+in+the+relief+of+bone+pain+%3A+a+double-blind+placebo-controlled+study+in+patients+with+prostate+cancer&rft.jtitle=British+journal+of+cancer&rft.au=KYLM%C3%84L%C3%84%2C+T&rft.au=TAUBE%2C+T&rft.au=TAMMELA%2C+T.+L.+J&rft.au=RISTELI%2C+L&rft.date=1997-01-01&rft.pub=Nature+Publishing+Group&rft.issn=0007-0920&rft.eissn=1532-1827&rft.volume=76&rft.issue=7&rft.spage=939&rft.epage=942&rft_id=info:doi/10.1038%2Fbjc.1997.488&rft.externalDBID=n%2Fa&rft.externalDocID=2812331
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-0920&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-0920&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-0920&client=summon